Mutant Huntingtin Causes Metabolic Imbalance by Disruption of Hypothalamic Neurocircuits (Q42486219)

1 November 2017

title

Mutant huntingtin causes metabolic imbalance by disruption of hypothalamic neurocircuits (English)

1 reference

1 November 2017

Mutant Huntingtin Causes Metabolic Imbalance by Disruption of Hypothalamic Neurocircuits (English)

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2011.02.013

29 November 2024

6

Jens C Brüning

1 reference

1 November 2017

3

Tomas Björklund

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:21459327

29 November 2024

Bengt-Frederik Belgardt

4

object named as

Bengt F. Belgardt

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:21459327

29 November 2024

5

Jan Mauer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:21459327

29 November 2024

7

Deniz Kirik

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:21459327

29 November 2024

author name string

Sofia Hult

1

1 reference

1 November 2017

Rana Soylu

2

1 reference

1 November 2017

Åsa Petersén

8

1 reference

1 November 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21459327

29 November 2024

publication date

1 April 2011

1 reference

1 November 2017

6 April 2011

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21459327

full work available at URL

29 November 2024

http://www.cell.com/article/S1550413111000866/pdf

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:21459327

https://api.elsevier.com/content/article/PII:S1550413111000866?httpAccept=text/xml

29 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2011.02.013

https://api.elsevier.com/content/article/PII:S1550413111000866?httpAccept=text/plain

29 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2011.02.013

29 November 2024

1 reference

1 November 2017

volume

13

1 reference

1 November 2017

issue

4

1 reference

1 November 2017

page(s)

428-439

1 reference

Hypocretin and melanin-concentrating hormone in patients with Huntington disease

1 November 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2011.02.013

Hormone and glucose signalling in POMC and AgRP neurons.

29 November 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2011.02.013

Hypothalamic and pituitary c-Jun N-terminal kinase 1 signaling coordinately regulates glucose metabolism

29 November 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2011.02.013

Progressive alterations in the hypothalamic-pituitary-adrenal axis in the R6/2 transgenic mouse model of Huntington's disease

29 November 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2011.02.013

Nonallele-specific silencing of mutant and wild-type huntingtin demonstrates therapeutic efficacy in Huntington's disease mice.

29 November 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2011.02.013

Targeted disruption of Huntingtin-associated protein-1 (Hap1) results in postnatal death due to depressed feeding behavior

29 November 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2011.02.013

Lentiviral-mediated delivery of mutant huntingtin in the striatum of rats induces a selective neuropathology modulated by polyglutamine repeat size, huntingtin expression levels, and protein length.

29 November 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2011.02.013

The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity

29 November 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2011.02.013

Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain

29 November 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2011.02.013

Therapeutic silencing of mutant huntingtin with siRNA attenuates striatal and cortical neuropathology and behavioral deficits

29 November 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2011.02.013

Distribution of grey matter atrophy in Huntington's disease patients: a combined ROI-based and voxel-based morphometric study.

29 November 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2011.02.013

Huntingtin-associated protein 1 (Hap1) mutant mice bypassing the early postnatal lethality are neuroanatomically normal and fertile but display growth retardation.

29 November 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2011.02.013

Sustained effects of nonallele-specific Huntingtin silencing

29 November 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2011.02.013

Enhanced orexin receptor-2 signaling prevents diet-induced obesity and improves leptin sensitivity

29 November 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2011.02.013

Changes in key hypothalamic neuropeptide populations in Huntington disease revealed by neuropathological analyses

29 November 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2011.02.013

Full-length human mutant huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesis in BACHD mice

29 November 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2011.02.013

Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity

29 November 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2011.02.013

A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes.

29 November 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2011.02.013

Hypothalamic and neuroendocrine changes in Huntington's disease

29 November 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2011.02.013

Huntington's disease: from pathology and genetics to potential therapies

29 November 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2011.02.013

CNS-targets in control of energy and glucose homeostasis

29 November 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2011.02.013

Mutant huntingtin's effects on striatal gene expression in mice recapitulate changes observed in human Huntington's disease brain and do not differ with mutant huntingtin length or wild-type huntingtin dosage

29 November 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2011.02.013

Glucose homeostasis in Huntington disease: abnormalities in insulin sensitivity and early-phase insulin secretion

29 November 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2011.02.013

A huntingtin-associated protein enriched in brain with implications for pathology

29 November 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2011.02.013

Lack of huntingtin-associated protein-1 causes neuronal death resembling hypothalamic degeneration in Huntington's disease

29 November 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2011.02.013

Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice

29 November 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2011.02.013

Dietary intake in adults at risk for Huntington disease: analysis of PHAROS research participants

29 November 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2011.02.013

Exendin-4 improves glycemic control, ameliorates brain and pancreatic pathologies, and extends survival in a mouse model of Huntington's disease

29 November 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2011.02.013

Corticotropin-releasing hormone-mediated pathway of leptin to regulate feeding, adiposity, and uncoupling protein expression in mice

29 November 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2011.02.013

Early energy deficit in Huntington disease: identification of a plasma biomarker traceable during disease progression

29 November 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2011.02.013

Orexin loss in Huntington's disease.

29 November 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2011.02.013

Adipose tissue dysfunction tracks disease progression in two Huntington's disease mouse models

29 November 2024

34

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2011.02.013

The current clinical management of Huntington's disease

29 November 2024

35

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2011.02.013

Hypothalamic involvement in Huntington's disease: an in vivo PET study

29 November 2024

36

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2011.02.013

Full-length huntingtin levels modulate body weight by influencing insulin-like growth factor 1 expression

29 November 2024

37

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2011.02.013

Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior

29 November 2024

38

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2011.02.013

Hypothalamic huntingtin-associated protein 1 as a mediator of feeding behavior

29 November 2024

39

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2011.02.013

Early changes in the hypothalamic region in prodromal Huntington disease revealed by MRI analysis

29 November 2024

40

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2011.02.013

Assessment of the nutrition status of patients with Huntington's disease.

29 November 2024

41

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2011.02.013

29 November 2024

42

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2011.02.013

Selective deletion of Bdnf in the ventromedial and dorsomedial hypothalamus of adult mice results in hyperphagic behavior and obesity.

29 November 2024

43

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2011.02.013

Increased metabolism in the R6/2 mouse model of Huntington's disease.

29 November 2024

44

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2011.02.013

Body weight is modulated by levels of full-length huntingtin

29 November 2024

45

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2011.02.013

Stereological methods for estimating the total number of neurons and synapses: issues of precision and bias

29 November 2024

46

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2011.02.013

Thermoregulatory and metabolic defects in Huntington's disease transgenic mice implicate PGC-1alpha in Huntington's disease neurodegeneration

29 November 2024

47

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2011.02.013

Mutant huntingtin fragment selectively suppresses Brn-2 POU domain transcription factor to mediate hypothalamic cell dysfunction

29 November 2024

48

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2011.02.013

A major role for perifornical orexin neurons in the control of glucose metabolism in rats

29 November 2024

49

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2011.02.013

Hypothalamic IKKbeta/NF-kappaB and ER stress link overnutrition to energy imbalance and obesity

29 November 2024

50

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2011.02.013

29 November 2024

Identifiers

1 reference

1 November 2017

1 reference